The approval means that Libtayo is now the first immunotherapy approved in Europe to treat advanced cervical cancer, regardless of PD-L1 expression or tumour histology.

Libtayo shows robust growth in specific cancers, although it faces stiff competition in broader indications, highlighting Regeneron’s ability to develop blockbuster drugs. Regeneron appears ...

Sanofi’s cancer immunotherapy Libtayo (cemiplimab) has a third US indication after the FDA approved it for certain untreated lung cancer patients. The approval in first-line lung cancer ...

One patient with Merkel cell carcinoma (MCC) achieved a durable complete response with 15 milligrams per kilogram (mg/kg) solnerstotug and Libtayo (cemiplimab) and remains on treatment at 42 or more ...

Despite these challenges, Regeneron's other drugs, particularly Dupixent and Libtayo, show promise for future growth and revenue generation. Given the current uncertainties and risks, I rate ...

Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils Approval marks the first new treatment approach for ...

Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils Approval marks the first new treatment approach for ...

Dr. Doris Day, a board-certified dermatologist, has barely any wrinkles at 62. She has had cosmetic treatments but said anyone can have youthful-looking skin. Day's tips include using an SPF cream ...

Tuberculosis (TB) is a bacterial infection that usually affects the lungs but can spread to other parts of the body, including the skin. Once it reaches the skin, TB can cause a variety of lesions ...

Eat this meal plan to cure your chronic health condition. Follow this exercise regime to balance your hormones. Is your face puffy? That’s due to cortisol; it can be rectified by completing ...